• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Madrigal Pharmaceuticals, Inc. - Common Stock (NQ:MDGL)

    490.81 +3.49 (+0.72%)
    Streaming Delayed Price Updated: 2:24 PM EST, Feb 18, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Madrigal Pharmaceuticals, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    News headline image
    12 Health Care Stocks Moving In Monday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    Why Madrigal Pharmaceuticals Stock Is Crushing It Today ↗
    The company reported stellar late-stage clinical trial results for its experimental NASH (nonalcoholic steatohepatitis) drug. 
    Via The Motley Fool
    News headline image
    Madrigal Pharmaceuticals, Cerevel Therapeutics And Some Other Big Stocks Moving Higher On Monday ↗
    U.S. stocks traded mixed, with the Nasdaq Composite dropping around 90 points on Monday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    News headline image
    Tesla's Bouncing, but This Nasdaq Stock Tripled Monday Morning ↗
    Good news can come in different forms. 
    Via The Motley Fool
    News headline image
    Why Is Viking Therapeutics (VKTX) Stock Up 67% Today? ↗
    Viking Therapeutics (VKTX) stock is taking off on Monday with heavy trading without any news from the biopharmaceutical company. 
    Via InvestorPlace
    News headline image
    Madrigal Shares Skyrocket After Successful NASH Study ↗
     
    Via Benzinga
    News headline image
    Analysts Believe Madrigal's Resmetirom Shows Impressive Overall Profile In Liver Fibrosis ↗
     
    Via Benzinga
    News headline image
    Recap: Madrigal Pharmaceuticals Q1 Earnings ↗
    Madrigal Pharmaceuticals (NASDAQ:MDGL) reported its Q1 earnings results on Monday, May 9, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
    Via Benzinga
    News headline image
    AJRD Stock Alert: What to Know as L3Harris Technologies Acquires Aerojet Rocketdyne ↗
    Aerojet Rocketdyne (AJRD) stock is on the move today as investors react to a $4.7 billion deal with L3Harris Technologies (LHX). 
    Via InvestorPlace
    News headline image
    Madrigal Pharmaceuticals Stock Is Up 200% In One Day, Here's Why
    Madrigal Pharmaceuticals announced positive results for a major clinical trial and shares are up more than 200% because of it. 
    Via MarketBeat
    News headline image
    Why Viking Therapeutics Stock Is Moving Alongside Madrigal Pharmaceuticals Shares Today ↗
    Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher Monday, in sympathy with Madrigal Pharmaceuticals Inc (NASDAQ: MDGL), which announced a suc 
    Via Benzinga
    News headline image
    Why Is Madrigal Pharmaceuticals (MDGL) Stock Up 216% Today? ↗
    Madrigal Pharmaceuticals (MDGL) stock is rocketing higher on Monday after sharing positive results from its NASH treatment. 
    Via InvestorPlace
    News headline image
    Madrigal Pharma Stock Triples After Knocking NASH Study Out Of The Park ↗
    The company hit both of its goals in a Phase 3 study of a pill for the liver disease. 
    Via Investor's Business Daily
    News headline image
    Madrigal Pharma's Kidney Disease Candidate Improves Liver, Cardiovascular Health ↗
    Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) has  
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Tesla, Amazon, Madrigal Pharma, Pfizer, Synaptogenix: Why These 5 Stocks Are Drawing Investors' Attention Today ↗
    Major Wall Street indices had closed in the red on Friday in the wake of a continued sell-off following the hawkish stance asserted by the Federal Reserve. Friday witnessed volatile trading as a large... 
    Via Benzinga
    News headline image
    2 Healthcare Stocks Poised to Rocket Higher in the 4th Quarter ↗
    These two healthcare stocks could deliver market-crushing gains by year's end. 
    Via The Motley Fool
    News headline image
    Madrigal Pharmaceuticals: Q3 Earnings Insights ↗
    Madrigal Pharmaceuticals (NASDAQ:MDGL) reported its Q3 earnings results on Thursday, November 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
    Via Benzinga
    News headline image
    10 Health Care Stocks Whale Activity In Today's Session ↗
    This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
    Via Benzinga
    News headline image
    10 Health Care Stocks With Whale Alerts In Today's Session ↗
    This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
    Via Benzinga
    News headline image
    10 Health Care Stocks With Whale Alerts In Today's Session ↗
    This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
    Via Benzinga
    News headline image
    Benzinga's Top Ratings Upgrades, Downgrades For July 8, 2022 ↗
     
    Via Benzinga
    News headline image
    Bear Market Rally Lifts HealthCare Stocks Off Bottom ↗
    Clearly we are in a biotech bear market with both diagnostics and vaccine revenues stalled. If gene editing stocks cannot offer breakthrough clinical news then stick with large cap biopharma. 
    Via Talk Markets
    News headline image
    Madrigal Announces Debt Funding Of $250M To Back Potential US Resmetirom Launch ↗
     
    Via Benzinga
    News headline image
    Tough Slogging Ahead for Investors, Diversification is Important ↗
    Speculative small/mid-cap biotech stocks hit new lows this past week with the XBI at a “triple bottom” about the $84 level only 10 points above the March 2020 lows. 
    Via Talk Markets
    News headline image
    Madrigal Pharmaceuticals: A "Best in Class" Biotech Buy ↗
    One of the few broadly positive binary events in biotechnology of late, Madrigal’s best-in-class NASH compound is well on its way with de-risked, late-stage clinical results. 
    Via Talk Markets
    News headline image
    Bear Market Bets In Biotech ↗
    Taken together, the SPDR S&P Biotech ETF easily broke below the long-term 200-week support for the first time since the pandemic originally hit the markets in March of 2020. 
    Via Talk Markets
    News headline image
    Earnings Scheduled For May 9, 2022 ↗
    Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million. 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's Intraday Session ↗
    Gainers SOC Telemed (NASDAQ:TLMD) shares increased by 333.5% to $2.79 during Thursday's regular session. Trading volume for this security as of 12:30 EST is 19.4... 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
    Gainers Madrigal Pharmaceuticals (NASDAQ:MDGL) shares rose 14.9% to $64.8 during Monday's pre-market session. The market value of their outstanding shares is at $1.1... 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.